Medical Services Sees Additional Opportunities in South America

May 3, 2005
Medical Services International Inc. (OTC: MSITF)  wishes to announce that the regulatory authorities in Peru have asked the Company to prepare and send the necessary kits and documentation to begin the approval process for the VScan Hepatitis B test kit. Previously, the Company had announced that it had received approval for its VScan HIV test kit in Peru. Based on current negotiations in Peru, it appears that Peru will need approximately 200,000 HIV test kits every two months for a total of 1,200,000 HIV test kits per year. The VScan HIV test kit is the only HIV test kit approved by regulatory authorities in Peru.
 

The Company continues to expand its presence in South America. Medical Services has been approached to supply VScan HIV, Hepatitis B and TB test kits to Chile. Medical Services expects to begin the necessary testing for regulatory approval in Chile within the next 10 days. Based on conversations with agencies in Chile involved with HIV testing, there is a need for up to 500,000 HIV rapid test kits per year that can be used in remote areas and that require no refrigeration or medical facilities. The VScan HIV 1&2 rapid test kit is ideally suited for this environment

 
About VScan ™

The VScan™ rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile, Malaria, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.

For further information contact:
Robert Talbot at 780-430-6363 or
Bill Whitehead, Jr., 416-822-5883

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF".